Posted in | News | Biofuels

UPM Successfully Complete EIA for Biofuel Refinery in Finland

The environmental impact assessment for a possible second generation biofuel refinery has been concluded in Rauma and Kuusankoski, Finland. The responsible authority, Southeast Finland Regional Environment Centre, has issued its official statement concerning the assessment. In the statement the authority commends that the assessment made by UPM is well prepared and includes a lot of information about the different implementation alternatives and their environmental impacts. The authority concluded that the assessment is sufficient and meets the requirements of the EIA law and statute.

UPM is also assessing alternative locations for a refinery producing transport biofuels at UPM's mill sites in other countries. UPM is now starting an environmental impact and risk assessment study as part of preparations for a permitting procedure in Strasbourg, France. The plan is to study the option of building a second generation biorefinery at the Stracel paper mill site. This process is estimated to last about a year.

UPM, together with Andritz/Carbona, has been testing the gasification technology needed to produce biofuel from forest energy wood near Chicago, USA. The initial testing program has been completed successfully. UPM is continuing to develop the technical concept and the technology solution is estimated to be ready by summer 2010.

- We are making necessary preparations both concerning the technical and the permit issues in the light of an investment decision. Time for the investment decision is not right now but later after the environmental impact assessments have been done and the final technical concept has been selected, comments Petri Kukkonen, director for UPM's biofuels business area.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.